SP1-Induced Upregulation of LncRNA AFAP1-AS1 Promotes Tumor Progression in Triple-Negative Breast Cancer by Regulating mTOR Pathway
Open Access
- 29 August 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (17) , 13401
Abstract
The long non-coding RNA (lncRNA) actin fiber-associated protein-1 antisense RNA 1 (AFAP1-AS1) exerted oncogenic activity in triple-negative breast cancer (TNBC). We designed this study and conducted it to investigate the upstream regulation mechanism of AFAP1-AS1 in TNBC tumorigenesis. In this work, we proved the localization of AFAP1-AS1 in the cytoplasm. We elucidated the mechanism by which the transcription factor specificity protein 1 (SP1) modulated AFAP1-AS1 in TNBC progression, which has yet to be thoroughly studied. Dual luciferase reporter assay and chromatin immunoprecipitation (ChIP) assay revealed a strong affinity of SP1 toward the promoter regions P3 of AFAP1-AS1, proving the gene expression regulation of AFAP1-AS1 via SP1 in TNBC. Additionally, SP1 could facilitate the tumorigenesis of TNBC cells in vitro and in vivo by regulating the AFAP1-AS1 expression. Furthermore, silenced AFAP1-AS1 suppressed the expression of genes in the mTOR pathway, such as eukaryotic translation initiation factor 4B (EIF4B), mitogen-activated protein kinase-associated protein 1 (MAPKAP1), SEH1-like nucleoporin (SEH1L), serum/glucocorticoid regulated kinase 1 (SGK1), and its target NEDD4-like E3 ubiquitin protein ligase (NEDD4L), and promoted the gene expression of s-phase kinase-associated protein 2 (SKP2). Overall, this study emphasized the oncogenic role of SP1 and AFAP1-AS1 in TNBC and illustrated the AFAP1-AS1 upstream interaction with SP1 and the downstream modulatory of mTOR signaling, thus offering insights into the tumorigenesis mechanism in TNBC.Keywords
Funding Information
- National High-level hospital clinical research Funding (2022-PUMCH-B-039, 2023-PUMCH-F-004, 32101043)
- National Natural Science Foundation of China (2022-PUMCH-B-039, 2023-PUMCH-F-004, 32101043)
This publication has 48 references indexed in Scilit:
- Biology and Management of Patients With Triple-Negative Breast CancerThe Oncologist, 2016
- Sp1 transcription factor: A long-standing target in cancer chemotherapyPharmacology & Therapeutics, 2015
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroupsNature, 2012
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networksBiochemical Journal, 2011
- A coding-independent function of gene and pseudogene mRNAs regulates tumour biologyNature, 2010
- Ubiquitin Ligase Nedd4L Targets Activated Smad2/3 to Limit TGF-β SignalingMolecular Cell, 2009
- Inhibition of Sp1 activity by a decoy PNA–DNA chimera prevents urokinase receptor expression and migration of breast cancer cellsBiochemical Pharmacology, 2005
- TOS Motif-Mediated Raptor Binding Regulates 4E-BP1 Multisite Phosphorylation and FunctionCurrent Biology, 2003
- The Mammalian Target of Rapamycin (mTOR) Partner, Raptor, Binds the mTOR Substrates p70 S6 Kinase and 4E-BP1 through Their TOR Signaling (TOS) MotifJournal of Biological Chemistry, 2003